Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 11.34% |
| 3 | Financials | 9.38% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Elbit Systems
ESLT
$36.5B
| $24M | ﹤0.01% |
126,272
-9,263
| -7% | -$2M |
|
2002
Nuveen Municipal Credit Opportunities Fund
NMCO
$589M
| $23.9M | ﹤0.01% |
2,234,311
-131,581
| -6% | -$1.68M |
|
2003
First Trust Europe AlphaDEX Fund
FEP
$534M
| $23.9M | ﹤0.01% |
907,017
-342,397
| -27% | -$10.4M |
|
2004
Brookfield Infrastructure
BIPC
$5.01B
| $23.9M | ﹤0.01% |
586,932
+176,465
| +43% | +$8.12M |
|
2005
Jackson Financial
JXN
$9.1B
| $23.9M | ﹤0.01% |
860,385
+107,777
| +14% | +$3.18M |
|
2006
Marathon Digital Holdings
MARA
$3.56B
| $23.9M | ﹤0.01% |
2,226,964
-676,876
| -23% | -$8.02M |
|
2007
Ambarella
AMBA
$3.6B
| $23.8M | ﹤0.01% |
423,760
+29,318
| +7% | +$2.17M |
|
2008
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$449M
| $23.8M | ﹤0.01% |
347,426
+26,097
| +8% | +$1.92M |
|
2009
MasTec
MTZ
$23B
| $23.8M | ﹤0.01% |
374,379
+82,085
| +28% | +$6.35M |
|
2010
Nu Skin
NUS
$236M
| $23.7M | ﹤0.01% |
711,445
+107,695
| +18% | +$4.48M |
|
2011
iShares Global Financials ETF
IXG
$702M
| $23.7M | ﹤0.01% |
387,159
+39,171
| +11% | +$2.63M |
|
2012
Ameresco
AMRC
$1.47B
| $23.7M | ﹤0.01% |
356,964
-9,843
| -3% | -$604K |
|
2013
Belden
BDC
$5.36B
| $23.7M | ﹤0.01% |
395,332
+35,823
| +10% | +$2.28M |
|
|
PLL
2014
DELISTED
Piedmont Lithium
PLL
| $23.7M | ﹤0.01% |
443,526
+327,413
| +282% | +$16.8M |
|
2015
Merit Medical Systems
MMSI
$5.4B
| $23.7M | ﹤0.01% |
419,550
-14,678
| -3% | -$845K |
|
2016
Invesco Food & Beverage ETF
PBJ
$109M
| $23.6M | ﹤0.01% |
562,659
-50,617
| -8% | -$2.29M |
|
2017
Community Bank
CBU
$3.46B
| $23.6M | ﹤0.01% |
393,217
+17,953
| +5% | +$1.18M |
|
2018
TriNet
TNET
$3.22B
| $23.6M | ﹤0.01% |
331,672
-16,753
| -5% | -$1.36M |
|
2019
Adicet Bio
ACET
$77.3M
| $23.6M | ﹤0.01% |
103,792
+1,683
| +2% | +$427K |
|
|
AMED
2020
DELISTED
Amedisys
AMED
| $23.6M | ﹤0.01% |
243,938
-14,442
| -6% | -$1.72M |
|
2021
Cogent Communications
CCOI
$530M
| $23.5M | ﹤0.01% |
451,270
+28,268
| +7% | +$1.63M |
|
2022
J&J Snack Foods
JJSF
$1.7B
| $23.5M | ﹤0.01% |
181,730
+12,771
| +8% | +$1.81M |
|
2023
Vertiv
VRT
$111B
| $23.5M | ﹤0.01% |
2,414,476
-442,787
| -15% | -$4.97M |
|
2024
Macerich
MAC
$6.99B
| $23.5M | ﹤0.01% |
2,955,527
-453,266
| -13% | -$4.4M |
|
2025
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $23.4M | ﹤0.01% |
119,525
+13,418
| +13% | +$2.74M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.